January 28 - 30, 2010 – Hyatt Regency, Maui, HI

T-cell lymphoma is divided into several different types, including T-cell Lymphoma, cutaneous T-cell lymphoma, and NK-cell lymphoma. Some subtypes of T-cell lymphoma are also associated with viral infections. T-cell lymphoma represents about 15% of non-Hodgkin's lymphoma cases in the United States, but T-cell Lymphoma occurs at a higher frequency in certain Asian populations. The classification system for T-cell neoplasms was recently updated by the World Health Organization, and several collaborative efforts, such as the International T-cell Lymphoma Project, have revealed new information that may aid in diagnosis and prognosis. However, treatment for these lymphomas remains a challenge, with a paucity of patients able to enroll in clinical trials.

This forum will provide a platform for discussion about the classification, epidemiology, prognosis, and pathogenesis of several T-cell lymphoma subtypes. In addition, the latest information on novel agents and treatment approaches will be presented by T-cell lymphoma experts.

This meeting is intended for hematologists, oncologists, and other clinicians and scientists with an interest in T-cell lymphoma.